OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 0925-AA55 View EO 12866 Meetings | Received Date: 03/11/2014 |
| Title: Clinical Trials Registration and Results Submission | |
| Agency/Subagency: HHS / NIH | Stage: Proposed Rule |
| Concluded Action: Consistent with Change | Concluded Date: 08/29/2014 |
| Legal Deadline: Statutory | Economically Significant: No |
| Publication Date: 11/21/2014 | Unfunded Mandates: No |
| Major: No | Related To Homeland Security: No |
| Regulatory Flexibility Analysis Required: Undetermined | Small Entities Affected: Businesses |
| Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
| International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
| Pandemic Response: Uncollected | |
An official website of the United States government




